NCT05947435View on ClinicalTrials.gov

Tranexamic Acid in Percutaneous Nephrolithotomy

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

June 1, 2023

Conditions
Percutaneous NephrolithotomyIntraoperative Use of Tranexamic Acid
Interventions
DRUG

Tranexamic acid

Tranexamic acid was administered in intravenous or locally within irrigation fluid

Trial Locations (1)

34000

Haseki Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Haseki Training and Research Hospital

OTHER

NCT05947435 - Tranexamic Acid in Percutaneous Nephrolithotomy | Biotech Hunter | Biotech Hunter